Key Event Details
A meeting of the Board of Directors of Valiant Laboratories Limited is scheduled to be held on Monday, November 02, 2026. The purpose of the meeting is to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and half year ended September 30, 2026.
Regulatory Compliance Information
The company has complied with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading. The Trading Window was closed effective September 29, 2026 and will remain closed until November 04, 2026.